Four things to know:
1. The company saw a 5.3% revenue increase year-over-year with $8 billion.
2. Medtronic’s neuroscience portfolio saw a 4.7% year-over-year increase with $2.28 billion.
3. The cranial and spinal technologies segment saw a 7% increase year-over-year with $1.2 billion.
4. Medtronic raised its revenue growth guidance to 4.75%.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
